Effect of neoadjuvant chemoradiotherapy on prognosis in resectable and borderline resectable pancreatic cancer with venous involvement.

被引：0
|
作者：
Nagai, Minako [1 ]
Sho, Masayuki [1 ]
Akahori, Takahiro [1 ]
Nakagawa, Kenji [1 ]
Nakamura, Kota [1 ]
Takagi, Tadataka [1 ]
Tanaka, Toshihiro [1 ]
Nishiofuku, Hideyuki [1 ]
Kichikawa, Kimihiko [1 ]
Ikeda, Naoya [1 ]
机构：
[1] Nara Med Univ, Kashihara, Nara, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.343
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
343
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +
  • [2] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Hayakawa, S.
    Karasawa, K.
    Fujisawa, T.
    Ito, K.
    Shibata, Y.
    Shimizuguchi, T.
    Nihei, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E236 - E236
  • [3] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [4] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    di Sebastiano, Pierluigi
    Grottola, Tommaso
    di Mola, F. Francesco
    UPDATES IN SURGERY, 2016, 68 (03) : 235 - 239
  • [5] Neoadjuvant fractionated versus hypofractionated chemoradiotherapy in resectable and borderline resectable pancreatic cancer
    Lee, Darren
    Nelson, Bailey
    Rai, Shesh
    Rai, Jayesh
    Wang, Kyle
    Sohal, Davendra
    Olowokure, Olugbenga Olanrele
    Rojan, Adam
    Patel, Sameer H.
    Wilson, Gregory
    Ahmad, Syed A.
    Kharofa, Jordan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    Pierluigi di Sebastiano
    Tommaso Grottola
    F. Francesco di Mola
    Updates in Surgery, 2016, 68 : 235 - 239
  • [7] Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Thanikachalam, Kannan
    Damarla, Vijay
    Seixas, Trevor
    Dobrosotskaya, Irina
    Wollner, Ira
    Kwon, David
    Winters, Kenneth
    Raoufi, Mohammad
    Li, Jia
    Siddiqui, Farzan
    Khan, Gazala
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 435 - 441
  • [8] Treatment strategy for borderline resectable pancreatic cancer with artery involvement.
    Hirono, Seiko
    Kawai, Manabu
    Okada, Ken-Ichi
    Miyazawa, Motoki
    Shimizu, Atsushi
    Kitahata, Yuji
    Ueno, Masaki
    Hayami, Shinya
    Yamaguchi, Shunsuke
    Takifuji, Katsunari
    Hotta, Tsukasa
    Nakamura, Masaki
    Matsuda, Kenji
    Yamaue, Hiroki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [9] Defining Venous Involvement in Borderline Resectable Pancreatic Cancer
    Yun Shin Chun
    Barton N. Milestone
    James C. Watson
    Steven J. Cohen
    Barbara Burtness
    Paul F. Engstrom
    Oleh Haluszka
    Jeffrey L. Tokar
    Michael J. Hall
    Crystal S. Denlinger
    Igor Astsaturov
    John P. Hoffman
    Annals of Surgical Oncology, 2010, 17 : 2832 - 2838
  • [10] Defining Venous Involvement in Borderline Resectable Pancreatic Cancer
    Chun, Y.
    Watson, J. C.
    Milestone, B. N.
    Hoffman, J. P.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S26 - S27
12345